Sit Investment Associates’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-45
Closed -$11K 564
2022
Q3
$11K Hold
45
﹤0.01% 515
2022
Q2
$11K Hold
45
﹤0.01% 510
2022
Q1
$15K Hold
45
﹤0.01% 511
2021
Q4
$16K Buy
+45
New +$15.2K ﹤0.01% 509
2021
Q3
Sell
-45
Closed -$14K 539
2021
Q2
$14K Hold
45
﹤0.01% 520
2021
Q1
$14K Hold
45
﹤0.01% 521
2020
Q4
$15K Hold
45
﹤0.01% 515
2020
Q3
$12K Hold
45
﹤0.01% 514
2020
Q2
$11K Hold
45
﹤0.01% 521
2020
Q1
$7K Hold
45
﹤0.01% 527
2019
Q4
$8K Sell
45
-3,690
-99% -$684K ﹤0.01% 513
2019
Q3
$664K Sell
3,735
-1,145
-23% -$248K 0.02% 362
2019
Q2
$1.27M Sell
4,880
-10,290
-68% -$2.73M 0.04% 323
2019
Q1
$4.33M Buy
15,170
+11,945
+370% +$3.97M 0.14% 178
2018
Q4
$1.05M Buy
3,225
+1,300
+68% +$452K 0.03% 325
2018
Q3
$866K Buy
1,925
+1,025
+114% +$404K 0.02% 350
2018
Q2
$368K Buy
+900
New +$326K 0.01% 443

Other funds holding ABMD

Sit Investment Associates's ABMD Position: Q4 2022 in Review

Sit Investment Associates sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 45 shares — an estimated $11K sold.

Sit Investment Associates first reported a position in ABMD in Q2 2018 and held it in 17 quarters. The position peaked at $4.33M in Q1 2019. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Sit Investment Associates reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Sit Investment Associates sold 45 Abiomed Inc shares in Q4 2022, an estimated $11K.
  • Sit Investment Associates first reported a position in Abiomed Inc in Q2 2018 and held it in 17 quarters.
  • Sit Investment Associates's Abiomed Inc position peaked at $4.33M in Q1 2019.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Sit Investment Associates's 13F filing for Q4 2022, filed 10 Feb 2023.